Robert Malkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert Malkin has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Billy Teninty
Global Medical Equipment Repair Training
2 shared publicationsChelsea Msc Whittle
Robert Malkin, PhD, PE, Duke University, 136 Hudson, #90281, Durham, NC 27708 ( [ protected])
2 shared publications- Alexa Choy
Division of Digestive Diseases Columbia University New York N.Y USA
1 shared publication Alexander P. Beng Dahinten
From the *Developing World Healthcare Technologies Lab, Duke University, Durham, North Carolina; †Department of Pediatrics, Duke University Medical Center, Durham, North Carolina; and ‡Department of Pediatrics, Kilimanjaro Christian Medical Centre, Moshi, Tanzania
1 shared publicationAlexander P. Dahinten
Developing World Healthcare Technologies Lab, Duke University, Durham, USA
1 shared publicationAllison Keane
Duke University
1 shared publication
Latest Publications
- 15 July 2025
- Published by Springer Nature
- p. 65-71
Donations of Medical Imaging Equipment in Global Health
- 15 July 2025
- Published by Springer Nature
- p. 65-71
Donations of Medical Imaging Equipment in Global Health
- Open Access
- 1 April 2024
- Published by Canadian Institute for Knowledge Development in Canadian Journal of Medicine
- Vol. 6 (1) , 5-14
Barriers and Facilitators Associated with the History of Colonization on the Vaccination Process of COVID-19 among Indigenous Peoples in Canada
Indigenous communities were identified as highly vulnerable during the COVID-19 pandemic, given their remote geographical location and high relative cumulative cases. Specific barriers and facilitators of vaccination in the communities must be studied to create better public health planning. This study conducted private, qualitative interviews in the Indigenous community with local adult residents. Convenience sampling was used and recruitment was conducted with support from trusted Indigenous community connections. Participants were included if they spoke English and spent the majority of their lifetime in the local community. We interviewed three participants (two women, and one man, ages of 54, 53, and 61 years old respectively), all of whom received two mandatory COVID-19 vaccines with two of them getting one booster shot. Interview questions asked for attitudes on the current vaccination process, the government and local health unit policies, the source of trust and mistrust, and future suggestions for vaccination policies. Participants identified cultural mistrust as a barrier as it refers to the hesitancy of residents due to historical and cultural contributors. Participants suggested mixed attitudes toward accessibility, source of information and local health unit policies, and vaccine mistrust and trust, identifying them as barriers and facilitators in different scenarios. This study brings vaccination-related issues to the attention of the Government of Canada and health officials, facilitating effective public health planning and long-term trust building with the Indigenous communities.
- 1 April 2024
- Published by Canadian Institute for Knowledge Development in Canadian Journal of Medicine
- Vol. 6 (1) , 5-14
Open AccessBarriers and Facilitators Associated with the History of Colonization on the Vaccination Process of COVID-19 among Indigenous Peoples in Canada
Indigenous communities were identified as highly vulnerable during the COVID-19 pandemic, given their remote geographical location and high relative cumulative cases. Specific barriers and facilitators of vaccination in the communities must be studied to create better public health planning. This study conducted private, qualitative interviews in the Indigenous community with local adult residents. Convenience sampling was used and recruitment was conducted with support from trusted Indigenous community connections. Participants were included if they spoke English and spent the majority of their lifetime in the local community. We interviewed three participants (two women, and one man, ages of 54, 53, and 61 years old respectively), all of whom received two mandatory COVID-19 vaccines with two of them getting one booster shot. Interview questions asked for attitudes on the current vaccination process, the government and local health unit policies, the source of trust and mistrust, and future suggestions for vaccination policies. Participants identified cultural mistrust as a barrier as it refers to the hesitancy of residents due to historical and cultural contributors. Participants suggested mixed attitudes toward accessibility, source of information and local health unit policies, and vaccine mistrust and trust, identifying them as barriers and facilitators in different scenarios. This study brings vaccination-related issues to the attention of the Government of Canada and health officials, facilitating effective public health planning and long-term trust building with the Indigenous communities.
- Open Access
- 1 November 2023
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 16, 1259-1265
Errors in Metered Dose Inhaler Use Amongst Pediatric Asthma Patients
Purpose: The aim of this paper is to use easily accessible smartphones as a straightforward means for physicians to objectively check Medical Device Inhaler (MDI) technique, without the need for additional devices. Additionally, we seek to assess the frequency of inhaler technique errors and their impact on asthma control. Patients and Methods: Thirty-two children between the ages of 5 and 18 receiving asthma therapy through MDIs were included. Three surveys were administered to all participants to gauge device history, asthma control, and patient characteristics. Patient technique was scored using inhaler audio signals recorded with a smartphone. For subjects that were able, forced oscillation technique (FOT) was performed during tidal breathing conditions before and after corticosteroid administration. Results: 81% (25/31) of participants used their MDIs incorrectly with the most common errors being rapid shallow breathing, inadequate breath-holding, and excessive actuations. Poor inhaler technique correlated with poorly controlled asthma symptoms. Conclusion: The use of smartphone recordings can a convenient way to evaluate technique errors and could allow patients to demonstrate and refine their technique and usage without a doctor’s visit, ensuring proper technique and enhancing treatment effectiveness.
- 1 November 2023
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 16, 1259-1265
Open AccessErrors in Metered Dose Inhaler Use Amongst Pediatric Asthma Patients
Purpose: The aim of this paper is to use easily accessible smartphones as a straightforward means for physicians to objectively check Medical Device Inhaler (MDI) technique, without the need for additional devices. Additionally, we seek to assess the frequency of inhaler technique errors and their impact on asthma control. Patients and Methods: Thirty-two children between the ages of 5 and 18 receiving asthma therapy through MDIs were included. Three surveys were administered to all participants to gauge device history, asthma control, and patient characteristics. Patient technique was scored using inhaler audio signals recorded with a smartphone. For subjects that were able, forced oscillation technique (FOT) was performed during tidal breathing conditions before and after corticosteroid administration. Results: 81% (25/31) of participants used their MDIs incorrectly with the most common errors being rapid shallow breathing, inadequate breath-holding, and excessive actuations. Poor inhaler technique correlated with poorly controlled asthma symptoms. Conclusion: The use of smartphone recordings can a convenient way to evaluate technique errors and could allow patients to demonstrate and refine their technique and usage without a doctor’s visit, ensuring proper technique and enhancing treatment effectiveness.
- 1 December 2022
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 427-436
HANDLINK: A Dexterous Robotic Hand Exoskeleton controlled by Motor Imagery (MI)
Introduction: Over 5.6 million stroke survivors in the United States experience hemiparesis of the upper limb. Assistive devices are used to help regain upper limb functionality for affected individuals; however, existing devices are bulky, costly, and lack adaptability. The objective of this pilot study was to test the performance of a newly developed hand exoskeleton on a sample of individuals with hand impairment. Methods: A hand exoskeleton was developed comprising of a novel linkage system with three four-bar linkages structures set up in a series and a novel algorithm that finds optimal Electroencephalogram (EEG) channels, through Common Spatial Pattern (CSP) Recognition, and classifies them with a stacked Linear Discriminant Analysis-Support Vector Machine (LDA-SVM) classifier. The functionality of the novel hand exoskeleton was tested by examining performance across a battery of hand mobility assessments among individuals in the experimental group with hand impairment (n=10) compared to controls (n=10). Results: A paired-t test was used to show better performance for the experimental group with the exoskeleton compared to those without the exoskeleton across function, grip force, and range of motion measures. An unpaired-t test was used to show that there was no statistical difference in the mean performance of the experimental group with the exoskeleton compared to the control group for most measures, indicating that functionality with the exoskeleton is comparable to a healthy hand. The LDA-SVM classifier resulted in an 88% accuracy in classifying which finger the user intends to move with minimal latency as a result of its computational efficiency. Conclusions: Findings suggest HANDLINK was effective in improving function, grip force, and range of motion among hand-impaired individuals. The HANDLINK, and its complementary stacked SVM-LDA classification algorithm, work as a viable solution for a fully adaptable and cost-effective assistive hand aide for individuals with paraplegia.
- 1 December 2022
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 427-436
HANDLINK: A Dexterous Robotic Hand Exoskeleton controlled by Motor Imagery (MI)
Introduction: Over 5.6 million stroke survivors in the United States experience hemiparesis of the upper limb. Assistive devices are used to help regain upper limb functionality for affected individuals; however, existing devices are bulky, costly, and lack adaptability. The objective of this pilot study was to test the performance of a newly developed hand exoskeleton on a sample of individuals with hand impairment. Methods: A hand exoskeleton was developed comprising of a novel linkage system with three four-bar linkages structures set up in a series and a novel algorithm that finds optimal Electroencephalogram (EEG) channels, through Common Spatial Pattern (CSP) Recognition, and classifies them with a stacked Linear Discriminant Analysis-Support Vector Machine (LDA-SVM) classifier. The functionality of the novel hand exoskeleton was tested by examining performance across a battery of hand mobility assessments among individuals in the experimental group with hand impairment (n=10) compared to controls (n=10). Results: A paired-t test was used to show better performance for the experimental group with the exoskeleton compared to those without the exoskeleton across function, grip force, and range of motion measures. An unpaired-t test was used to show that there was no statistical difference in the mean performance of the experimental group with the exoskeleton compared to the control group for most measures, indicating that functionality with the exoskeleton is comparable to a healthy hand. The LDA-SVM classifier resulted in an 88% accuracy in classifying which finger the user intends to move with minimal latency as a result of its computational efficiency. Conclusions: Findings suggest HANDLINK was effective in improving function, grip force, and range of motion among hand-impaired individuals. The HANDLINK, and its complementary stacked SVM-LDA classification algorithm, work as a viable solution for a fully adaptable and cost-effective assistive hand aide for individuals with paraplegia.
- 19 December 2021
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 284-291
The Effect of Vaping and Nicotine-containing Liquids to Suppress the Immune System: A Pilot Study
Aims: We present a pilot study to illustrate how the impact of vaping can be quickly and conclusively documented in a large population and appropriate subpopulations. Methods: It has been predicted that with longer duration and higher frequency of vaping, there would be a higher frequency of, a longer duration of, and more severe flu and cold symptoms — indicating a negative impact on the immune system. Studies have linked electronic cigarettes and vaping to respiratory and cardiovascular issues, drastic changes in blood pressure, and the reduced function of tissues and cells in the lungs, but only in small populations, making generalization to the entire population less convincing. A sample of 120, 18–22-year-olds in northern California were asked to complete a 14-question, two-minute, anonymous survey. Those with pre-existing respiratory ailments or a family history of respiratory ailments were excluded from the study along with those who smoke cigarettes or have smoked cigarettes in the past. The survey collected the frequency and time spent vaping and the severity, frequency, and longevity of the flu and cold symptoms. Responses were converted into numerical values and analyzed. Results: Those who vaped more often had more severe flu and cold symptoms (pConclusion: A quick survey was created to show the negative effects of vaping on a general population. Showing effects generalizable to the entire population would require a very reasonably sized sample and could easily allow analysis of subpopulations.
- 19 December 2021
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 284-291
The Effect of Vaping and Nicotine-containing Liquids to Suppress the Immune System: A Pilot Study
Aims: We present a pilot study to illustrate how the impact of vaping can be quickly and conclusively documented in a large population and appropriate subpopulations. Methods: It has been predicted that with longer duration and higher frequency of vaping, there would be a higher frequency of, a longer duration of, and more severe flu and cold symptoms — indicating a negative impact on the immune system. Studies have linked electronic cigarettes and vaping to respiratory and cardiovascular issues, drastic changes in blood pressure, and the reduced function of tissues and cells in the lungs, but only in small populations, making generalization to the entire population less convincing. A sample of 120, 18–22-year-olds in northern California were asked to complete a 14-question, two-minute, anonymous survey. Those with pre-existing respiratory ailments or a family history of respiratory ailments were excluded from the study along with those who smoke cigarettes or have smoked cigarettes in the past. The survey collected the frequency and time spent vaping and the severity, frequency, and longevity of the flu and cold symptoms. Responses were converted into numerical values and analyzed. Results: Those who vaped more often had more severe flu and cold symptoms (pConclusion: A quick survey was created to show the negative effects of vaping on a general population. Showing effects generalizable to the entire population would require a very reasonably sized sample and could easily allow analysis of subpopulations.
- 1 January 2019
- Published by Springer Nature
- p. 77-83
Medical Imaging in Global Public Health: Donation, Procurement, Installation, and Maintenance
- 1 January 2019
- Published by Springer Nature
- p. 77-83
Medical Imaging in Global Public Health: Donation, Procurement, Installation, and Maintenance
- 23 June 2018
- Published by Springer Nature in Health and Technology
- Vol. 8 (4) , 291-300
A sustainability evaluation of a biomedical technician training program in Honduras
- 23 June 2018
- Published by Springer Nature in Health and Technology
- Vol. 8 (4) , 291-300
A sustainability evaluation of a biomedical technician training program in Honduras
- 1 September 2016
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 35 (9) , 987-991
Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-exposed Newborns via a Novel Drug Delivery System in Tanzania
Background: In developing countries, antiretroviral therapy provides life-saving treatment to HIV-positive women and their children before, during and after birth. However, supply chain challenges such as long distances, medication shortages and nonfacility deliveries often compromise consistent access to prophylactic treatment for at-risk infants. A proposed intervention to address these challenges, often referred to as the “Pratt Pouch,” allows for liquid-formulation medications, such as nevirapine (NVP), to be repackaged into single-dose pouches. These pouches are distributed antenatally. Methods: HIV-positive women at Kilimanjaro Christian Medical Centre in Moshi, Tanzania received 14 pouches each containing a single dose of NVP for prevention of mother-to-child transmission. Women were trained on how to open the pouch and dispense the medication to their infants after delivery. All participating women were asked to return to Kilimanjaro Christian Medical Centre 7–14 days after delivery, where infant blood spots were collected to assess NVP levels. Results: All enrolled women (21/21) administered NVP to their infants within 24 hours of birth. All enrolled infants (22/22) had NVP blood concentrations over 100 ng/mL and exhibited no health concerns attributable to over or under dosing. Conclusions: The Pratt Pouch intervention provides a clinically appropriate solution for addressing liquid-formulation antiretroviral access challenges in developing countries.
- 1 September 2016
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 35 (9) , 987-991
Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-exposed Newborns via a Novel Drug Delivery System in Tanzania
Background: In developing countries, antiretroviral therapy provides life-saving treatment to HIV-positive women and their children before, during and after birth. However, supply chain challenges such as long distances, medication shortages and nonfacility deliveries often compromise consistent access to prophylactic treatment for at-risk infants. A proposed intervention to address these challenges, often referred to as the “Pratt Pouch,” allows for liquid-formulation medications, such as nevirapine (NVP), to be repackaged into single-dose pouches. These pouches are distributed antenatally. Methods: HIV-positive women at Kilimanjaro Christian Medical Centre in Moshi, Tanzania received 14 pouches each containing a single dose of NVP for prevention of mother-to-child transmission. Women were trained on how to open the pouch and dispense the medication to their infants after delivery. All participating women were asked to return to Kilimanjaro Christian Medical Centre 7–14 days after delivery, where infant blood spots were collected to assess NVP levels. Results: All enrolled women (21/21) administered NVP to their infants within 24 hours of birth. All enrolled infants (22/22) had NVP blood concentrations over 100 ng/mL and exhibited no health concerns attributable to over or under dosing. Conclusions: The Pratt Pouch intervention provides a clinically appropriate solution for addressing liquid-formulation antiretroviral access challenges in developing countries.
- Open Access
- 22 March 2016
- Published by Bentham Science Publishers Ltd. in The Open Biomedical Engineering Journal
- Vol. 10 (1) , 12-18
The Pratt Pouch Provides a Three-Fold Access Increase to Antiretroviral Medication for Births outside Health Facilities in Southern Zambia
Introduction: Modern day antiretroviral therapy allows HIV+ pregnant women to lower the likelihood of viral transmission to their infants before, during, and after birth from 20-45% to less than 5%. In developing countries, where non-facility births may outnumber facility births, infant access to safe antiretroviral medication during the critical first three days after birth is often limited. A single-dose, polyethylene pouch (“Pratt Pouch”) addresses this challenge by allowing the medication to be distributed to mothers during antenatal care. Methods: The Pratt Pouch was introduced as part of a one year clinical feasibility study in two districts in Southern Province, Zambia. Participating nurses, community health workers, and pharmacists were trained before implementation. Success in achieving improved antiretroviral medication access was assessed via pre intervention and post intervention survey responses by HIV+ mothers. Results: Access to medication for HIV-exposed infants born outside of a health facility increased from 35% (17/51) before the introduction of the pouch to 94% (15/16) after (p0.05). Results remained below the national average homebirth rate of 52%. Users reported minimal spillage and a high level of satisfaction with the Pratt Pouch. Conclusion: The Pratt Pouch enhances access to infant antiretroviral medication in a rural, non-facility birth setting. Wide scale implementation could have a substantial global impact on HIV transmission rates from mother to child.
- 22 March 2016
- Published by Bentham Science Publishers Ltd. in The Open Biomedical Engineering Journal
- Vol. 10 (1) , 12-18
Open AccessThe Pratt Pouch Provides a Three-Fold Access Increase to Antiretroviral Medication for Births outside Health Facilities in Southern Zambia
Introduction: Modern day antiretroviral therapy allows HIV+ pregnant women to lower the likelihood of viral transmission to their infants before, during, and after birth from 20-45% to less than 5%. In developing countries, where non-facility births may outnumber facility births, infant access to safe antiretroviral medication during the critical first three days after birth is often limited. A single-dose, polyethylene pouch (“Pratt Pouch”) addresses this challenge by allowing the medication to be distributed to mothers during antenatal care. Methods: The Pratt Pouch was introduced as part of a one year clinical feasibility study in two districts in Southern Province, Zambia. Participating nurses, community health workers, and pharmacists were trained before implementation. Success in achieving improved antiretroviral medication access was assessed via pre intervention and post intervention survey responses by HIV+ mothers. Results: Access to medication for HIV-exposed infants born outside of a health facility increased from 35% (17/51) before the introduction of the pouch to 94% (15/16) after (p0.05). Results remained below the national average homebirth rate of 52%. Users reported minimal spillage and a high level of satisfaction with the Pratt Pouch. Conclusion: The Pratt Pouch enhances access to infant antiretroviral medication in a rural, non-facility birth setting. Wide scale implementation could have a substantial global impact on HIV transmission rates from mother to child.
- Open Access
- 1 June 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (25) , e1030
Accurate Dosing of Antiretrovirals at Home Using a Foilized, Polyethylene Pouch to Prevent the Transmission of HIV From Mother to Child
Mother-to-child HIV transmission rates remain elevated in countries with high home birth rates. This risk can be dramatically reduced if infants receive antiretroviral (ARV) medication within 24 hours after birth. However, many barriers prevent access to these medications immediately after delivery, for example, there is currently no suitable mechanism to preserve predosed ARVs in the home during the months before birth. In response to this, students of the Duke University developed the Pratt pouch, a foilized polyethylene packet designed to preserve predosed ARVs. This cross-sectional study presents the data from the first clinical trials of the Pratt pouch in Guayaquil, Ecuador. Fourteen HIV-positive mothers and nurses were observed using the pouch to deliver a dose of ARVs to an infant. Weight measurements, time, and notes on spillage were taken at each observation period. Successful usage was quantitatively assessed through the calculation of dosing accuracy based on the volume of liquid medication emptied from the pouch. Additionally, mothers were surveyed after a month of using the device at home to assess their perception of the accuracy, acceptability, and ease of use of the pouch. Used pouches were collected for physical analysis of tearing. Observed users delivered accurate doses (M = 101.1%, standard deviation = 8.2%) in an average time of 2.6 minutes. A total of 2869 used pouches were recovered. No seal failures or failed attempts at opening/delivering the pouches were observed or detected. Forty-three mothers were surveyed. All mothers (100%) reported that they were able to follow their physician's treatment plan, all pouches were received in good condition and the pictorial sheets provided clear instructions. We conclude that the Pratt pouch is a highly accurate and easy-to-use device for delivering liquid oral ARVs to infants and is appropriate for prepackaging ARVs for home use.
- 1 June 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (25) , e1030
Open AccessAccurate Dosing of Antiretrovirals at Home Using a Foilized, Polyethylene Pouch to Prevent the Transmission of HIV From Mother to Child
Mother-to-child HIV transmission rates remain elevated in countries with high home birth rates. This risk can be dramatically reduced if infants receive antiretroviral (ARV) medication within 24 hours after birth. However, many barriers prevent access to these medications immediately after delivery, for example, there is currently no suitable mechanism to preserve predosed ARVs in the home during the months before birth. In response to this, students of the Duke University developed the Pratt pouch, a foilized polyethylene packet designed to preserve predosed ARVs. This cross-sectional study presents the data from the first clinical trials of the Pratt pouch in Guayaquil, Ecuador. Fourteen HIV-positive mothers and nurses were observed using the pouch to deliver a dose of ARVs to an infant. Weight measurements, time, and notes on spillage were taken at each observation period. Successful usage was quantitatively assessed through the calculation of dosing accuracy based on the volume of liquid medication emptied from the pouch. Additionally, mothers were surveyed after a month of using the device at home to assess their perception of the accuracy, acceptability, and ease of use of the pouch. Used pouches were collected for physical analysis of tearing. Observed users delivered accurate doses (M = 101.1%, standard deviation = 8.2%) in an average time of 2.6 minutes. A total of 2869 used pouches were recovered. No seal failures or failed attempts at opening/delivering the pouches were observed or detected. Forty-three mothers were surveyed. All mothers (100%) reported that they were able to follow their physician's treatment plan, all pouches were received in good condition and the pictorial sheets provided clear instructions. We conclude that the Pratt pouch is a highly accurate and easy-to-use device for delivering liquid oral ARVs to infants and is appropriate for prepackaging ARVs for home use.